More accurately, phenylbutyrate application induced the CDK inhibitors p21CIP1 and p27KIP1 and caused a dose-dependent cervical cancer cell growth arrest by augmenting the G1 fraction [102]. Here, CDKN1A is linked to cervical carcinoma.